• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Gastroenterol Gastrointestinal Bleeding in Patients With Severe SARS-CoV-2

tetano

Editor, Senior Moderator
Am J Gastroenterol


. 2020 Jun 4.
doi: 10.14309/ajg.0000000000000719. Online ahead of print.
Gastrointestinal Bleeding in Patients With Severe SARS-CoV-2


Chiranjeevi Gadiparthi[SUP] 1 [/SUP], Abhilash Perisetti[SUP] 2 [/SUP], Hari Sayana[SUP] 3 [/SUP], Benjamin Tharian[SUP] 2 [/SUP], Sumant Inamdar[SUP] 2 [/SUP], Andrew Korman[SUP] 1 [/SUP]



Affiliations

Abstract

Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.
 
Back
Top Bottom